Cyanotech to Hold Investor Broadcast on Friday, August 11, 2017

KAILUA KONA, Hawaii–(BUSINESS WIRE)–Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in
microalgae-based, high-value nutrition and health products will host a
Skype broadcast at 5:00 p.m. EDT on Friday, August 11, 2017 to respond
to questions about its operating results and other topics of interest.
Interested parties are asked to submit questions to [email protected]
before 5:00 p.m. EDT on Thursday, August 10, 2017. The Company will
respond to relevant questions only, and will not be accepting any
questions or comments during the broadcast.

To join the broadcast, please browse http://cyanotech.com/meet
approximately five minutes prior to the start time.

Financial results for the quarter ended June 30, 2017 will be available
prior to the conference call. A transcript of the broadcast will be
available on the Company’s website (www.cyanotech.com)
for approximately one week after completion of the broadcast.

About Cyanotech — Cyanotech Corporation, a world leader in
microalgae technology for over 30 years, produces BioAstin® Hawaiian
Astaxanthin® and Hawaiian Spirulina Pacifica®. These all natural,
dietary ingredients and supplements leverage our experience and
reputation for quality, building nutritional brands which promote health
and well-being. The Company’s mission is to fulfill the promise of whole
health through Hawaiian microalgae. Cyanotech’s BioAstin® offers
superior antioxidant activity which supports skin, eye and joint health,
as well as recovery from exercise*. Cyanotech’s Spirulina products offer
nutrition that supports cardiovascular health and immunity.* All
Cyanotech products are produced from microalgae grown at our 90-acre
facility in Kona, Hawaii using patented and proprietary technology and
are Generally Recognized as Safe (GRAS) for use in food products.
Cyanotech sells its products direct to consumers at retail locations in
the United States and online at www.nutrex-hawaii.com
and also distributes to dietary supplement, nutraceutical and
cosmeceutical manufacturers and marketers. The Company is regulated by
the FDA. Visit www.cyanotech.com
for more information.

*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.

“Safe Harbor” Statement under the U.S. Private Securities Litigation
Reform Act of 1995 Besides statements of present fact and historical
fact, this press release may contain forward-looking statements.
Forward-looking statements relate to the future and are subject to
inherent uncertainties, risks and changes in circumstances that are
difficult to predict. Our actual results may differ materially from
those contemplated by forward-looking statements. We caution against
relying on forward-looking statements. Important factors that could
change actual, future results include: changes in sales levels to our
largest customers, weather patterns in Hawaii, production problems,
risks associated with new products, foreign exchange fluctuations, and
availability of financing, as well as national and global political,
economic, business, competitive, market and regulatory conditions. Other
factors are more fully detailed in the Company’s annual Form 10-K
filings with the Securities and Exchange Commission.

Contacts

Cyanotech Corporation
Bruce Russell, 310-346-6131
[email protected]